Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia

Clinical Chemistry

Volumn 45, Issue 2, 1999, Pages 184-188

  Lo, Y M Dennis ^a   Leung, Tse N ^a   Tein, Mark S C ^a   Sargent, Ian L ^b   Zhang, Jun ^a   Lau, Tze K ^a   Haines, Christopher J ^a   Redman, Christopher W G ^c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; FETUS; HUMAN; MALE; NUCLEIC ACID TRANSPORT; PLACENTAL TRANSFER; POLYMERASE CHAIN REACTION; PREECLAMPSIA; QUANTITATIVE ASSAY;

EID: 0032992867     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.2.184     Document Type: Article

References (28)

1. Raptis L, Menard HA. Quantitation and characterisation of plasma DNA in normals and patients with systemic lupus erythematosus. J Clin Investig 1980;66:1391-9.
2. Dennin RH. DNA of free and complexed origin in human plasma: concentration and length distribution. Klin Wochenschr 1979;57:451-6.
3. Nawroz H, Koch W, Anker P, Stroun M, Sidransky D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 1996;2:1035-7.
4. Mulcahy HE, Lyautey J, Lederrey C, Chen XQ, Anker P, Alstead EM, et al. A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Clin Cancer Res 1998;4:271-5.
5. Hibi K, Robinson R, Booker S, Wu L, Hamilton SR, Sidransky D, Jen J. Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res 1998;58:1405-7.
6. Lo YMD, Tein MSC, Pang CCP, Yeung CK, Tong KL, Hjelm NM. Presence of donor-specific DNA in plasma of kidney and liver transplant recipients [Letter]. Lancet 1998;351:1329-30.
7. Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CWG, Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-7.
8. Lo YMD, Tein MSC, Lau TK, Haines CJ, Leung TN, Poon PMK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-75.
9. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of the Thermus aquaticus DNA polymerase. Proc Natl Acad Sci U S A 1991;88:7276-80.
10. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986-94.
11. Luthra R, McBride JA, Cabanillas F, Sarris A. Novel 5′ exonuclease-based real-time PCR assay for the detection of t (14;18)(q32;q21) in patients with follicular lymphoma. Am J Pathol 1998;153:63-8.
12. Chua S, Wilkins T, Sargent I, Redman C. Trophoblast deportation in pre-eclamptic pregnancy. Br J Obstet Gynaecol 1991;98:973-9.
13. Holzgreve W, Ghezzi F, DiNaro E, Ganshirt D, Maymon E, Hahn S. Disturbed feto-maternal cell traffic in preeclampsia. Obstet Gynecol 1998;91:669-72.
14. Chen XQ, Stroun M, Magnenat J-L, Nicod LP, Kurt A-M, Lyautey J, et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 1996;2:1033-5.
15. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989;339:237-8.
16. Longo MC, Berninger MS, Hartley JL. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene 1990;93:125-8.
17. Fournie GJ, Martres F, Pourrat JP, Alary C, Rumeau M. Plasma DNA as cell death marker in elderly patients. Gerontology 1993;39:215-21.
18. Fournie GJ, Courtin JP, Laval F, Chale JJ, Pourrat JP, Pujazon MC, et al. Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett 1995;91:221-7.
19. Jones CJ, Fox H. An ultrastructural and ultrahistochemical study of the human placenta in maternal preeclampsia. Placenta 1980;1:61-76.
20. Smith SC, Baker PN, Symonds EM. Placental apoptosis in normal human pregnancy. Am J Obstet Gynecol 1997;177:57-65.
21. Tsumita T, Iwanaga M. Fate of injected deoxyribonucleic acid in mice. Nature 1963;198:1088-9.
22. Emlen W, Mannik M. Effect of DNA size and strandedness on the in vivo clearance and organ localization of DNA. Clin Exp Immunol 1984;56:185-92.
23. Roberts JM, Redman CWG. Pre-eclampsia: more than pregnancy-induced hypertension [Review]. Lancet 1993;341:1447-51.
24. Lo YMD, Lo ESF, Watson N, Noakes L, Sargent IL, Thilaganathan B, Wainscoat JS. Two-way cell traffic between mother and fetus: biologic and clinical implications. Blood 1996;88:4390-5.
25. Bianchi DW, Flint AF, Pizzimenti MF, Knoll JH, Latt SA. Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc Natl Acad Sci U S A 1990;87:3279-83.
26. Bischoff FZ, Lewis DE, Nguyen DD, Murrell S, Schodber W, Scott J, et al. Prenatal diagnosis with use of fetal cells isolated from maternal blood: five-color fluorescent in situ hybridization analysis on flow-sorted cells for chromosomes X, Y, 13, 18, and 21. Am J Obstet Gynecol 1998;179:203-9.
27. Muttukrishna S, Knight PG, Groome NP, Redman CWG, Ledger WL. Activin A, inhibin A as possible endocrine markers for pre-eclampsia. Lancet 1997;349:1285-8.
28. Anker P, Lefort F, Vasioukhin V, Lyautey J, Lederrey C, Chen XQ, et al. K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology 1997;112:1114-20.